Long-term follow-up shows 95% success rate, no serious complications in largest ADA-SCID gene therapy study to date ...
A groundbreaking gene therapy has successfully restored immune function in children with ADA-SCID, a severe genetic disorder.
CEBU, Philippines – Since it opened in Cebu last June, the Regenestem brand has gained a solid reputation for spreading the many benefits of stem cell therapy. In fact, the brand has become synonymous ...
The study, published in the New England Journal of Medicine, marks the largest and longest follow-up of this gene therapy to ...